Organogenesis Holdings Inc.

Item 1. Legal Proceedings

As disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, on January 22, 2025, the Company was served with a complaint captioned United States of America, State of Texas, ex rel. John Doe vs. Organogenesis Holdings, Inc., which was filed in the United States District Court for the Southern District of Texas. The complaint was brought by an employee the Company terminated. The United States and the State of Texas each declined to intervene in the case in September 2024. The complaint alleged claims pursuant to the United States False Claims Act and the Texas State Medicaid Fraud Prevention Act, seeking unquantified damages as well as fines, attorneys’ fees and other costs. On March 31, 2025, the Company filed a Motion to

Dismiss the Complaint in its entirety. On May 19, 2025, shortly before a response was due, the plaintiff filed a notice of dismissal without prejudice which was accepted by the Court. The United States and the State of Texas both consented to the dismissal.

We are not a party to any other material legal proceedings. From time to time, we may become involved in litigation or other legal proceedings relating to claims arising from the ordinary course of business. These matters may include intellectual property, employment and other general claims. With respect to our outstanding legal matters, based on our current knowledge, we believe that the amount or range of reasonably possible loss will not, either individually or in the aggregate, have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties.